SCHEMBL29692811

SCHEMBL29692811

CC(C)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)N[C@H](C(=O)Oc1c(F)c(F)c(F)c(F)c1F)C(C)C

nearest known ligand 0.58

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ CTSB P07858 1/20 0.48
▸ CTSK P43235 1/20 0.48
▸ PTPN1 P18031 6/20 0.48
▸ CASP3 P42574 2/20 0.46
▸ MDM4 O15151 2/20 0.42
▸ TP53 P04637 2/20 0.42
▸ MDM2 Q00987 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5706460 0.91 PTPN1 (0.48) PTPN1CASP3MDM4TP53MDM2
SCHEMBL29401221 0.91 PTPN1 (0.48) PTPN1CASP3MDM4TP53MDM2
SCHEMBL29400612 0.91 PTPN1 (0.48) PTPN1CASP3MDM4TP53MDM2
SCHEMBL29368798 0.89 CASP3 (0.52) CASP3MDM4TP53MDM2
SCHEMBL29401786 0.89 CASP3 (0.52) CASP3MDM4TP53MDM2
SCHEMBL30656017 0.89 CASP3 (0.52) CASP3MDM4TP53MDM2
SCHEMBL3070048 0.89 CASP3 (0.52) CASP3MDM4TP53MDM2
SCHEMBL30375087 0.86 CTSK (0.53) CTSBCTSKPTPN1CASP3MDM4
SCHEMBL29692856 0.86 CASP3 (0.44) PTPN1CASP3MDM4TP53MDM2
SCHEMBL2066552 0.83 MDM4 (0.47) CASP3MDM4TP53MDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113150108-B Solid-phase synthesis method of liraglutide 台州吉诺生物科技有限公司 2022-07-22 — — CN claimed
CN-113444164-B Solid-phase synthesis method of Somalutide 台州吉诺生物科技有限公司 2022-07-19 — — CN claimed
CN-113150108-B Solid-phase synthesis method of liraglutide 台州吉诺生物科技有限公司 2022-07-22 — — CN disclosed
CN-113444164-B Solid-phase synthesis method of Somalutide 台州吉诺生物科技有限公司 2022-07-19 — — CN disclosed
Send feedback